Cambridge Independent on MSN1d
Promising ‘Trojan horse’ potential therapies against Alzheimer’s and other diseases developed by Cambridge scientists
The TRIM21 therapies have been shown to remove toxic tau proteins and reduce symptoms of neurodegeneration in mice.
New therapy that targets and destroys tau tangles: A promising Alzheimer's disease treatment
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
Cambridge Network4d
New therapy that targets and destroys tau tangles is a promising future Alzheimer’s disease treatment
Other techniques for targeting tau inside cells, such as anti-sense oligonucleotides (ASOs), have been shown to reduce tau in ...
News Medical on MSN6d
Scientists develop selective therapy for tau tangles
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
Trailhead Biosystems Announces Joshua Snow as Chief Commercial Officer
Trailhead Biosystems, Inc. (trailbio.com), a biotechnology company creating iPSC-derived human cells at scale for drug discovery and cell therapy, welcomes Josh Snow as Chief Commercial Officer.
Revolution, interrupted: Why AI has failed to live up to the hype in drug development
Dion Madsen, co-founder of Montreal-based Amplitude Ventures, was an early believer in the power of AI to improve drug ...
FierceBiotech17h
In 2 papers, researchers describe potential new neurodegenerative disease treatment approach
To turn TRIM21 into a treatment, McEwan and James, of the Medical Research Council Laboratory of Molecular Biology in ...
PipelineReview.com7d
Nona Biosciences Enters into Collaboration Agreement with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, MA, USA I 12, 2024 I Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced ...
chronicle.lu1d
Virology Professor Alain Kohl Discusses Mosquitoes
The warmer summers and milder winters experienced in Luxembourg over the last few years may sometimes seem like... }} ...
Pharmabiz6d
Nona Biosciences collaborates with Umoja Biopharma to advance in vivo CAR-T cell therapies
Nona Biosciences collaborates with Umoja Biopharma to advance in vivo CAR-T cell therapies: Cambridge, Massachusetts Saturday, September 14, 2024, 11:00 Hrs [IST] Nona Biosciences ...
Posts Sharing Mpox Misinformation Recycle Claims from Prior Viral Outbreaks
Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...
The EMBO Journal3d
IF1 is a cold-regulated switch of ATP synthase hydrolytic activity to support thermogenesis in brown fat
How the hydrolytic activity of mitochondrial ATP synthase is modulated during brown adipose tissue (BAT) thermogenesis ...